Masimo | MASI

Stock Price
147.19
Daily Change
4.18 2.92%
Monthly
1.76%
Yearly
31.97%
Q3 Forecast
145.97

Peers Price Chg Day Year Date
Abbott 132.94 0.13 0.10% 16.68% Sep/05
Align Technology 139.12 4.42 3.28% -37.08% Sep/05
AtriCure 35.38 -0.28 -0.79% 34.83% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Dexcom 80.51 -0.25 -0.31% 17.11% Sep/05
Edwards Lifesciences 80.94 -0.02 -0.02% 21.19% Sep/05
General Electric Aerospace 279.23 -3.04 -1.08% 73.26% Sep/05
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Haemonetics 54.38 0.30 0.55% -25.75% Sep/05
Integra LifeSciences 15.99 0.34 2.17% -13.57% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Owens Minor 5.62 0.22 4.07% -63.72% Sep/05
Insulet 348.43 1.96 0.57% 62.25% Sep/05
ResMed 277.05 3.24 1.18% 13.23% Sep/05
Steris 245.30 1.91 0.78% 2.42% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
Tandem Diabetes Care 12.58 0.19 1.53% -70.33% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
USND 21700 -7.31 -0.03% 30.01% Sep/05
US2000 2391 11.44 0.48% 14.33% Sep/05
US400 3297 16.31 0.50% 12.16% Sep/05

Masimo traded at $147.19 this Friday September 5th, increasing $4.18 or 2.92 percent since the previous trading session. Looking back, over the last four weeks, Masimo gained 1.76 percent. Over the last 12 months, its price rose by 31.97 percent. Looking ahead, we forecast Masimo to be priced at 145.97 by the end of this quarter and at 142.36 in one year, according to Trading Economics global macro models projections and analysts expectations.

Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive technologies and hospital automation solutions. Its patient monitoring solution that incorporates a monitor or circuit board, single-patient use or reusable sensors, software and cables. The Company’s main products include Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include noninvasive monitoring of blood constituents with an optical signature, optical regional oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain. It sells its products hospitals, emergency medical service (EMS) providers, home care providers, long-term care facilities, physician offices, veterinarians and consumers through direct sales force, distributors and original equipment manufacturers (OEM) partners.